BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4287557)

  • 1. [On the duration and conditions of survival in a group of subjects operated on for glioblastoma multiforme].
    Perniola T; Tamburro G
    Osp Psichiatr; 1965; 33(3):233-50. PubMed ID: 4287557
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surgery of glioblastoma multiforme and its follow-up results].
    Matsukado Y; Kitamura K
    No To Shinkei; 1967 Dec; 19(12):1251-7. PubMed ID: 4296379
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer trends: glioblastoma multiforme and radiation therapy.
    Peeples WJ; El-Mahdi AM
    Va Med; 1980 Feb; 107(2):113-6, 120-1. PubMed ID: 6245550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of glioblastoma multiforme.
    Jelsma RK; Bucy PC
    Trans Am Neurol Assoc; 1967; 92():90-3. PubMed ID: 4329419
    [No Abstract]   [Full Text] [Related]  

  • 5. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
    Kong DS; Nam DH; Lee JI; Park K; Kim JH
    J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dose-volume relationships in the treatment of glioblastoma multiforme.
    Aristizibal SA; Caldwell WL
    Radiology; 1971 Oct; 101(1):201-2. PubMed ID: 4106953
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of glioblastoma multiforme of the brain.
    Jelsma R; Bucy PC
    J Neurosurg; 1967 Nov; 27(5):388-400. PubMed ID: 4293835
    [No Abstract]   [Full Text] [Related]  

  • 9. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
    Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of postoperative radiation therapy of glioblastoma multiforme in relation to dose distribution].
    Ragaĭshene VN
    Med Radiol (Mosk); 1974 May; 19(5):47-53. PubMed ID: 4368115
    [No Abstract]   [Full Text] [Related]  

  • 11. Experiences with reoperation on recurrent glioblastoma multiforme.
    Pinsker M; Lumenta C
    Zentralbl Neurochir; 2001; 62(2):43-7. PubMed ID: 11786935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical treatment and radiation therapy for glioblastoma multiforme, with special reference to intraoperative radiotherapy].
    Matsutani M; Matsuda T; Nagashima T; Kohno T; Hoshino T; Terao H
    Gan No Rinsho; 1984 Apr; 30(4):325-33. PubMed ID: 6328061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
    Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
    No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
    Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma: the past, the present, and the future.
    Wilson CB
    Clin Neurosurg; 1992; 38():32-48. PubMed ID: 1311227
    [No Abstract]   [Full Text] [Related]  

  • 18. Short course of radiation therapy in elderly patients with glioblastoma multiforme.
    Idbaih A; Taillibert S; Simon JM; Psimaras D; Schneble HM; Lopez S; Lang P; Toubiana T; Feuvret L; Delattre JY; Mazeron JJ
    Cancer Radiother; 2008 Dec; 12(8):788-92. PubMed ID: 19046921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
    Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
    Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative hypofractionated radiotherapy in glioblastoma multiforme.
    Arslan M; Karadeniz AN; Aksu G; Güveli M; Fayda M; Doğan AK; Akyüz F
    J BUON; 2006; 11(1):39-42. PubMed ID: 17318950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.